DOI: http://dx.doi.org/10.18203/2349-3933.ijam20193670

Clinical profile of diabetes in young adults aged 15 to 30 years

Jimnaz P. A., Nishad N., Harris P.

Abstract


Background: There is a shift in age of onset of diabetes to a younger age in the recent years. There are very few data available on diabetes in the youth. Hence the study has been undertaken. Objective of the study is to describe the clinical profile of young diabetics and to estimate burden of selected end organ complications at the time of study.

Methods: A hospital based Cross sectional study was conducted at a tertiary care centre among 75 young diabetic patients (aged 15-30 years). After taking informed consent, detailed history clinical examination, biochemical investigations like FBS and 2 hours PPBS, HbA1c, lipid profile, screening for neuropathy, retinopathy and nephropathy were done.

Results: The mean age of the study population was 26.35±3.8 years, majority were males (62.7 %), 77.3% have positive family history. Mean BMI was 24.8±4.6 kg/m2, 45.3% were overweight ,20 % were obese. The mean FBS levels was 216.63±73.46 mg/dl, 2 hr PPBS 261.51±80.0 mg/dl and mean HbA1c 8.66±1.34 %. The total cholesterol level was higher in 46.7%, with mean of 198.4±21.0. Mean triglyceride level was 136.99±38.9. Nephropathy was present in 25.3%, retinopathy in 13.3% and neuropathy in 9.3 % of the patients. 30.6% had at least one of the three complications. SBP was associated with neuropathy(p=0.030), DBP with retinopathy(p=0.029) and neuropathy(p=0.007) and high FBS levels with retinopathy(p<0.001) and neuropathy(p<0.001).

Conclusion: Microvascular complications in young diabetes is alarmingly high. Regular screening, early detection, adequate control of FBS and BP may improve quality of life.


Keywords


Neuropathy, Retinopathy, Young diabetes

Full Text:

PDF

References


World Health Organization. Diabetes Fact sheet N°312. http://www.who.int/. 2015. p. Fact sheets. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/.

Drouin P, Blickle JF, Charbonnel B, Eschwege E, Guillausseau PJ, Plouin PF, et al. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(1):S62-7.

Ezzati M. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4??4 million participants. Lancet. 2016;387(10027):1513-30.

King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.

Narayan KMV, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes - A common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000 Oct;50(2):S77-84.

Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2013;128(16):e240-327.

Liu LL, Yi JP, Beyer J, Mayer-Davis EJ, Dolan LM, Dabelea DM, et al. Type 1 and type 2 diabetes in Asian and Pacific Islander U.S. youth. Diabetes Care. 2009;32(2);S133-40.

Amutha A, Datta M, Unnikrishnan IR, Anjana RM, Rema M, Venkat Narayan KM, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes. 2011;5(4):223-9.

WHO. HbA1c in the diagnosis of type 2 diabetes : a systematic review Introduction. Who Rep. 2006;(Who):1-27.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.

National Cholesterol Education Program (NCEP) Expert Panel. National Cholesterol Education Program: Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: Executive Summary. Arch Intern Med. 1991;151(6):1071-84.

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008;25(4):407-12.

Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 Years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34(10):1055-8.

Naing NN, Mohammad WZW, Bachock N, Hamzah TNT, Abdullah S, Suhami FF, et al. Characteristics of tuberculosis patients in a University Teaching Hospital in Kelantan, Malaysia. Int Med J. 2008;15(1):13-8.

Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737-47.

Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J. 2000;6(1):43-52.

Zhang Y-N, He L. [Risk factors study of ischemic stroke in young adults in Southwest China]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43(4):553-7.

Ferrannini E, Cushman WC. Diabetes and hypertension: The bad companions. Lancet. 2012;380(9841):601-10.

Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et al. Urban rural differences in prevalence of self-reported diabetes in India-The WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract. 2008;80(1):159-68.

Harris MI. Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care. 1991;14(5):366-74.

Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150-9.

Abdel-Aal NM, Ahmad AT, Froelicher ES, Batieha AMS, Hamza MM, Ajlouni KM. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan. Saudi Med J. 2008;29(10):1423-8.

Olsen BS, Sjolie AK, Hougaard P, Johannesen J, Borch-Johnsen K, Marinelli K, et al. A 6-year nationwide cohort study of glycaemic control in young people with Type 1 diabetes: Risk markers for the development of retinopathy, nephropathy and neuropathy. J Diabetes Complications. 2000;14(6):295-300.

Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care. 2012;35(6):1265-71.

McGrath NM, Parker GN, Dawson P. Early presentation of type 2 diabetes mellitus in young New Zealand Maori. Diabetes Res Clin Pract. 1999;43(3):205-9.

Caird FI, Pirie A, Ramsell TG. Diabetes and the Eye. Oxford, England, Blackwell Scientific Publications. 1968:76-77,93-100.

Frank RN, Hoffman WH PM. Retinopathy in juvenile-onset diabetes of short duration. Ophthalmol. 1980;87:1-10.

Lestradet H, Papoz L, Hellouin de Menibus C, Levavasseur F, Besse J, Billaud L, et al. Long-term study of mortality and vascular complications in juvenile-onset (type I) diabetes. Diabetes. 1981;30(3):175-9.

Sharma T, Raman R, Pal S, Rani P, Rachapalli S, Kulothungan V. Prevalence and risk factors for severity of diabetic neuropathy in type 2 diabetes mellitus. Indian J Med Sci. 2010;64(2):51.

Raman R, Gupta A, Krishna S, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). J Diabetes Complications. 2012;26(2):123-8.

Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: A prospective study. Diabetes Care. 1994;17(6):557-60.

Tanaka S, Tanaka S, Iimuro S, Yamashita H, Katayama S, Akanuma Y, et al. Predicting macro- and microvascular complications in type 2 diabetes: The japan diabetes complications study/the japanese elderly diabetes intervention trial risk engine. Diabetes Care. 2013;36(5):1193-9.